Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Neuronetics Inc STIM | 44 | Elevated | Healthcare | United States | 5 / 6 | $216M |
| Voyager Therapeutics Inc VYGR | 61 | Stretched | Healthcare | United States | 5 / 6 | $211M |
| Coherus Biosciences Inc CHRS | 67 | Stretched | Healthcare | United States | 5 / 6 | $209M |
| HEALIOS K.K. 6VX | 63 | Stretched | Healthcare | Japan | 5 / 6 | $208M |
| Bicycle Therapeutics Plc BCYC | 42 | Elevated | Healthcare | United Kingdom | 5 / 6 | $208M |
| Oramed Pharmaceuticals Inc ORMP | 62 | Stretched | Healthcare | United States | 4 / 6 | $207M |
| Protalix BioTherapeutics Inc PLX | 48 | Elevated | Healthcare | United States | 5 / 6 | $207M |
| ASCOM HLDG NA SF 0,50 AH2N | 41 | Elevated | Healthcare | Switzerland | 4 / 6 | $206M |
| AOTI Inc AOTI | 29 | Normal | Healthcare | United States | 5 / 6 | $206M |
| CAMP4 Therapeutics Corp CAMP | 60 | Stretched | Healthcare | United States | 5 / 6 | $206M |
| Pyxis Oncology Inc PYXS | 75 | Stretched | Healthcare | United States | 4 / 6 | $206M |
| Journey Medical Corp DERM | 49 | Elevated | Healthcare | United States | 4 / 6 | $205M |
| Innate Pharma IPHA | 76 | Stretched | Healthcare | France | 5 / 6 | $204M |
| American Well Corporation - Class A AMWL | 65 | Stretched | Healthcare | United States | 5 / 6 | $203M |
| Precision Biosciences Inc DTIL | 56 | Elevated | Healthcare | United States | 5 / 6 | $202M |
| Alpha Cognition Inc ACOG | 91 | Acute | Healthcare | United States | 3 / 6 | $202M |
| Trinity Biotech Plc TRIB | 76 | Stretched | Healthcare | Ireland | 5 / 6 | $200M |
| Pro-Dex Inc (co) PDEX | 35 | Normal | Healthcare | United States | 5 / 6 | $198M |
| Bastide Le Confort Médical SA BLC | 36 | Normal | Healthcare | France | 5 / 6 | $198M |
| ONWARD MEDICAL BV EO -12 63E | 43 | Elevated | Healthcare | Netherlands | 5 / 6 | $195M |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. R9Z | 43 | Elevated | Healthcare | China | 5 / 6 | $192M |
| Monash Ivf Group Ltd MVF | 48 | Elevated | Healthcare | Australia | 4 / 6 | $189M |
| Limes Schlosskliniken AG LIK | 14 | Contained | Healthcare | Germany | 5 / 6 | $188M |
| Bioversys AG BIOV | 67 | Stretched | Healthcare | Switzerland | 4 / 6 | $188M |
| Lucid Diagnostics Inc LUCD | 48 | Elevated | Healthcare | United States | 5 / 6 | $187M |
| Icecure Medical Ltd ICCM | 51 | Elevated | Healthcare | Israel | 5 / 6 | $185M |
| Korro Bio Inc KRRO | 75 | Stretched | Healthcare | United States | 4 / 6 | $184M |
| EDAP TMS S.A. EDAP | 55 | Elevated | Healthcare | France | 5 / 6 | $180M |
| Airsculpt Technologies Inc AIRS | 53 | Elevated | Healthcare | United States | 4 / 6 | $178M |
| Exagen Inc XGN | 37 | Normal | Healthcare | United States | 5 / 6 | $178M |
| OrganiGram Holdings Inc OGI | 29 | Normal | Healthcare | Canada | 5 / 6 | $171M |
| Lifecore Biomedical Inc LFCR | 58 | Elevated | Healthcare | United States | 5 / 6 | $168M |
| Quantum-Si Incorporated - Class A QSI | 62 | Stretched | Healthcare | United States | 4 / 6 | $168M |
| Saniona AB SANION | 11 | Contained | Healthcare | Denmark | 4 / 6 | $167M |
| Humacyte Inc HUMA | 69 | Stretched | Healthcare | United States | 4 / 6 | $167M |
| WW International Inc WW | 54 | Elevated | Healthcare | United States | 4 / 6 | $167M |
| Diaceutics PLC DXRX | 15 | Contained | Healthcare | United Kingdom | 5 / 6 | $166M |
| Adagene Inc ADAG | 54 | Elevated | Healthcare | China | 5 / 6 | $165M |
| Centrale dAchat Française pour lOutre-Mer Société Anonyme ALCGM | 27 | Normal | Healthcare | France | 5 / 6 | $165M |
| LENZ Therapeutics Inc LENZ | 56 | Elevated | Healthcare | United States | 4 / 6 | $164M |
| Caribou Biosciences Inc CRBU | 67 | Stretched | Healthcare | United States | 5 / 6 | $163M |
| MediWound Ltd MDWD | 81 | Acute | Healthcare | Israel | 5 / 6 | $163M |
| Quipt Home Medical Corp QIPT | 25 | Normal | Healthcare | United States | 5 / 6 | $162M |
| Zhaoke Ophthalmology Limited 9FX | 69 | Stretched | Healthcare | China | 5 / 6 | $161M |
| Athens Medical C.S.A. IATR | 46 | Elevated | Healthcare | Greece | 5 / 6 | $160M |
| Kazia Therapeutics Ltd KZIA | 62 | Stretched | Healthcare | Australia | 4 / 6 | $157M |
| PHOTOCURE ASA NK-50 PHS | 30 | Normal | Healthcare | Norway | 3 / 6 | $157M |
| Nyxoah SA NYXH | 51 | Elevated | Healthcare | Belgium | 5 / 6 | $156M |
| Codexis Inc CDXS | 56 | Elevated | Healthcare | United States | 5 / 6 | $155M |
| YONGHE MED.GR.DL-0000025 L97 | 22 | Normal | Healthcare | China | 5 / 6 | $155M |
| KANAMIC NETWORK CO. O.N. 0WT | 13 | Contained | Healthcare | Japan | 5 / 6 | $153M |
| KORU Medical Systems Inc KRMD | 30 | Normal | Healthcare | United States | 5 / 6 | $152M |
| Assertio Holdings Inc ASRT | 49 | Elevated | Healthcare | United States | 3 / 6 | $151M |
| OptimizeRx Corp OPRX | 26 | Normal | Healthcare | United States | 4 / 6 | $150M |
| NRX Pharmaceuticals Inc NRXP | 65 | Stretched | Healthcare | United States | 3 / 6 | $150M |
| Adc Therapeutics SA ADCT | 52 | Elevated | Healthcare | Switzerland | 5 / 6 | $149M |
| Nexalin Technology Inc NXL | 84 | Acute | Healthcare | United States | 3 / 6 | $149M |
| LifeMD Inc LFMD | 31 | Normal | Healthcare | United States | 4 / 6 | $148M |
| EKF Diagnostics Holdings Plc EKF | 29 | Normal | Healthcare | United Kingdom | 5 / 6 | $147M |
| BICO Group AB BICO | 33 | Normal | Healthcare | Sweden | 4 / 6 | $146M |
| Entera Bio Ltd ENTX | 66 | Stretched | Healthcare | Israel | 4 / 6 | $145M |
| Milestone Pharmaceuticals Inc MIST | 75 | Stretched | Healthcare | Canada | 4 / 6 | $144M |
| Vytrus Biotech S.A. VYT | 10 | Contained | Healthcare | Spain | 5 / 6 | $144M |
| Inogen Inc INGN | 38 | Normal | Healthcare | United States | 5 / 6 | $144M |
| Owlet Inc - Class A OWLT | 36 | Normal | Healthcare | United States | 5 / 6 | $143M |
| Hyloris Developmentsen Sa HYL | 55 | Elevated | Healthcare | Belgium | 4 / 6 | $143M |
| Empro Group Inc EMPG | 33 | Normal | Healthcare | Malaysia | 5 / 6 | $143M |
| Scancell Hldgs Plc SCLP | 72 | Stretched | Healthcare | United Kingdom | 4 / 6 | $142M |
| Inspecs Group plc SPEC | 40 | Elevated | Healthcare | United Kingdom | 5 / 6 | $142M |
| Stereotaxis Inc STXS | 54 | Elevated | Healthcare | United States | 5 / 6 | $141M |
| Connect Biopharma Holdings Ltd CNTB | 64 | Stretched | Healthcare | United States | 5 / 6 | $139M |
| MaxCyte Inc MXCT | 60 | Stretched | Healthcare | United States | 5 / 6 | $137M |
| Sedana Medical AB SEDANA | 41 | Elevated | Healthcare | Sweden | 4 / 6 | $136M |
| PW MEDTECH GROUP DL-0001 PWE | 33 | Normal | Healthcare | China | 5 / 6 | $136M |
| Japan Medical Dynamic Marketing INC JMD | 47 | Elevated | Healthcare | Japan | 5 / 6 | $135M |
| Cue Biopharma Inc CUE | 42 | Elevated | Healthcare | United States | 5 / 6 | $133M |
| ARRAIL GROUP LTD. I1D | 38 | Normal | Healthcare | China | 5 / 6 | $129M |
| Apyx Medical Corp APYX | 58 | Elevated | Healthcare | United States | 4 / 6 | $128M |
| Insight Molecular Diagnostics Inc IMDX | 58 | Elevated | Healthcare | United States | 4 / 6 | $128M |
| CURATIS N AG CURN | 36 | Normal | Healthcare | Switzerland | 4 / 6 | $128M |
| Quanterix Corp QTRX | 75 | Stretched | Healthcare | United States | 5 / 6 | $126M |
| 26U 26U | 34 | Normal | Healthcare | Switzerland | 4 / 6 | $125M |
| Dimerix Ltd DXB | 42 | Elevated | Healthcare | Australia | 4 / 6 | $124M |
| Cibus Global Ltd. Class A CBUS | 59 | Elevated | Healthcare | United States | 4 / 6 | $124M |
| Bioventix BVXP | 35 | Normal | Healthcare | United Kingdom | 4 / 6 | $124M |
| NeOnc Technologies Holdings Inc NTHI | 68 | Stretched | Healthcare | United States | 4 / 6 | $123M |
| Health Catalyst Inc HCAT | 61 | Stretched | Healthcare | United States | 4 / 6 | $122M |
| Black Diamond Therapeutics Inc BDTX | 27 | Normal | Healthcare | United States | 4 / 6 | $121M |
| Fonar Corp FONR | 31 | Normal | Healthcare | United States | 4 / 6 | $120M |
| Joint Corp JYNT | 40 | Elevated | Healthcare | United States | 5 / 6 | $120M |
| C-Rad AB (publ) CRAD-B | 15 | Contained | Healthcare | Sweden | 3 / 6 | $119M |
| Outlook Therapeutics Inc OTLK | 77 | Stretched | Healthcare | United States | 3 / 6 | $118M |
| Genelux Corp GNLX | 69 | Stretched | Healthcare | United States | 5 / 6 | $118M |
| Meihua International Medical Technologies Co Ltd - Class A MHUA | 43 | Elevated | Healthcare | China | 5 / 6 | $115M |
| Pomdoctor Ltd POM | 71 | Stretched | Healthcare | China | 5 / 6 | $112M |
| 4BASEBIO UK SOCIETAS 4BB | 43 | Elevated | Healthcare | United Kingdom | 5 / 6 | $109M |
| Seer Inc - Class A SEER | 44 | Elevated | Healthcare | United States | 5 / 6 | $108M |
| Vita Life Sciences Ltd VLS | 21 | Normal | Healthcare | Australia | 4 / 6 | $108M |
| Arcticzymes Technologies ASA B4V | 54 | Elevated | Healthcare | Norway | 4 / 6 | $108M |
| Inovio Pharmaceuticals Inc INO | 72 | Stretched | Healthcare | United States | 5 / 6 | $105M |
By sector
Industrials 1,536Technology 1,292Healthcare 1,214Consumer Cyclical 1,116Basic Materials 577Communication Services 565Real Estate 552Consumer Defensive 536Energy 356Utilities 232
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.